• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROCEPT BIOROBOTICS CORPORATION AQUABEAM ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROCEPT BIOROBOTICS CORPORATION AQUABEAM ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM Back to Search Results
Model Number AB2000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 08/21/2020
Event Type  Injury  
Manufacturer Narrative
Investigation by manufacturer is currently in-process.
 
Event Description
A male patient underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).Procept biorobotics corporation became aware that 26 days post-aquablation procedure the patient was admitted to a hospital and was administered two units of blood transfusion.Efforts to obtain additional information regarding the reported event have been unsuccessful; however, the bleeding is unlikely related to the aquablation procedure.No malfunction of the aquabeam robotic system was reported.
 
Manufacturer Narrative
A review of hte the aquabeam robotic system's log file was conducted, which confirmed no malfunctions were observed during the aquablation procedure.The review of the log file indicated that the system functioned as designed.A review of the device history record (dhr) for serial number (b)(6) was conducted, which confirmed that there were no nonconformances generated during the manufacturing process of this system.The review indicated that the system met all required specifications upon release for distribution.A review for similar complaints was performed on serial number (b)(6), which confirmed that there were no other similar events reported on this system.A review for similar events across all systems confirmed no other similar events.The aquabeam robotic system's instructions for use (ifu), ifu0101-00, rev.D, was reviewed and states the following: 3.Contraindications: do not use the aquabeam robotic system in patients who do not meet the indication for the system's intended use.4.3.Warnings: procedure: as with any surgical urologic procedure, potential perioperative risks of the aquablation procedure include: o bleeding.A root cause for the reported event could not be determined.The patient was transfused 26 days post-aquablation procedure; however, the bleeding is unlikely related to the procedure.No further information could be gathered from the treating physician.Based on the review of the log file, dhr, and ifu, the reported event is considered to be not device related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AQUABEAM ROBOTIC SYSTEM
Type of Device
FLUID JET REMOVAL SYSTEM
Manufacturer (Section D)
PROCEPT BIOROBOTICS CORPORATION
900 island drive
suite 101
redwood city CA 94065 1494
MDR Report Key10693861
MDR Text Key211859485
Report Number3012977056-2020-00049
Device Sequence Number1
Product Code PZP
UDI-Device IdentifierB614AB20001
UDI-PublicB614AB20001
Combination Product (y/n)N
PMA/PMN Number
DEN170024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 12/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberAB2000
Device Catalogue NumberAB2000
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/17/2020
Initial Date FDA Received10/16/2020
Supplement Dates Manufacturer Received12/21/2020
Supplement Dates FDA Received12/29/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-